Solcitinib
N-[5-[4-(3,3-dimethylazetidine-1-carbonyl)phenyl]-[1,2,4]triazolo[1,5-a]pyridin-2-yl]cyclopropanecarboxamide
Molecular Identity
Solcitinib
N-[5-[4-(3,3-dimethylazetidine-1-carbonyl)phenyl]-[1,2,4]triazolo[1,5-a]pyridin-2-yl]cyclopropanecarboxamide
PubChem CID: 44603362
2D Structure
Properties
C22H23N5O2
Molecular Formula
389.40
Molecular Weight
g/mol
389.1852
Exact Mass
Da
2.8
XLogP
Drug-like (Lipinski: < 5)
79.6
TPSA
Good oral absorption (< 140 A²)
1
H-Bond Donors
4
H-Bond Acceptors
648
Complexity
SMILES
Canonical SMILES
SMILES: CC1(CN(C1)C(=O)C2=CC=C(C=C2)C3=CC=CC4=NC(=NN43)NC(=O)C5CC5)CIsomeric SMILES
SMILES: CC1(CN(C1)C(=O)C2=CC=C(C=C2)C3=CC=CC4=NC(=NN43)NC(=O)C5CC5)CSynonyms(20)
Solcitinib1206163-45-2GLPG-0778GLPG0778GSK2586184AGSK-2586184GSK-2586184AN-(5-(4-(3,3-Dimethylazetidine-1-carbonyl)phenyl)-[1,2,4]triazolo[1,5-a]pyridin-2-yl)cyclopropanecarboxamideN-[5-[4-(3,3-dimethylazetidine-1-carbonyl)phenyl]-[1,2,4]triazolo[1,5-a]pyridin-2-yl]cyclopropanecarboxamideG154578GLPG-07883V7GQ1260KG-154578N-{5-[4-(3,3-dimethylazetidine-1-carbonyl)phenyl]-[1,2,4]triazolo[1,5-a]pyridin-2-yl}cyclopropanecarboxamidesolcitinibum
Data from PubChem (NCBI)
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Drug Network
Trials and conditions connected to Solcitinib
Loading drug network...